Today’s article highlights three biotech stocks you may want to consider. Here’s what they had to say, “Small-cap biotech stocks have the ability to produce eye-popping gains — and even double, in short order. In the same breath, they also have the capacity to wreak havoc on your portfolio if things go the wrong way in the clinic or on the regulatory front.” To read more, CLICK HERE.